Asset Allocation

As of August 31, 2026.
Type % Net
Cash 53.36%
Stock 42.61%
Bond 4.09%
Convertible 0.00%
Preferred 0.00%
Other -0.07%
View Asset Allocation
Start Trial

Market Capitalization

As of August 31, 2026
Large 100.0%
Mid 0.00%
Small 0.00%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 52.53%    % Emerging Markets: 0.01%    % Unidentified Markets: 47.46%

Americas 10.03%
9.96%
Canada 0.01%
United States 9.95%
0.06%
As of August 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 42.49%
United Kingdom 10.07%
32.42%
Belgium 0.44%
Denmark 0.80%
France 7.77%
Germany 5.74%
Ireland 0.00%
Italy 1.93%
Netherlands 5.18%
Spain 2.87%
Switzerland 7.69%
0.00%
0.00%
Greater Asia 0.03%
Japan 0.01%
0.01%
Australia 0.01%
0.01%
Singapore 0.00%
South Korea 0.01%
0.00%
Unidentified Region 47.46%

Bond Credit Quality Exposure

AAA 15.09%
AA 8.09%
A 4.77%
BBB 7.47%
BB 1.25%
B 0.40%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 57.00%
Not Available 5.92%
Short Term 0.00%
As of August 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
29.51%
Materials
2.74%
Consumer Discretionary
4.38%
Financials
22.40%
Real Estate
0.00%
Sensitive
34.16%
Communication Services
1.33%
Energy
6.67%
Industrials
15.98%
Information Technology
10.19%
Defensive
26.28%
Consumer Staples
8.15%
Health Care
14.49%
Utilities
3.64%
Not Classified
0.00%
Non Classified Equity
0.00%
As of August 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of August 31, 2026
Type % Net
Government 0.70%
Corporate 10.66%
Securitized 30.44%
Municipal 0.00%
Other 58.20%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.74%
Less than 1 Year
2.74%
Intermediate
12.80%
1 to 3 Years
5.72%
3 to 5 Years
3.91%
5 to 10 Years
3.17%
Long Term
29.23%
10 to 20 Years
15.37%
20 to 30 Years
6.41%
Over 30 Years
7.45%
Other
55.23%
As of August 31, 2026
View Bond Maturity Exposure
Start Trial